Hans Minderman

Roswell Park Comprehensive Cancer Center — United States

Medicine · Health Sciences

37h-index5.1kcitations195works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(35), Drug Transport and Resistance Mechanisms(26), Colorectal Cancer Treatments and Studies(22), Immunotherapy and Immune Responses(20), Cancer therapeutics and mechanisms(19)

Publications194 total

Mitochondrial cargo quality determines the paracrine effects of extracellular vesicles derived from vascular endothelial cells
Biomedicine & Pharmacotherapy·2025Open Access
Vδ2 unconventional T cells in the donor graft are associated with improved overall survival after unrelated donor allo-HCT for AML and MDS: An analysis from the DKMS and NMDP graft composition study
Blood·2025Open Access
NK receptor signaling lowers the TCR activation threshold: role in selective recognition of cancer cells, but not healthy tissues, by TAA-specific CTLs 2687
The Journal of Immunology·2025Open Access
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma
Cancer Cell·2025· 4 citedOpen Access
Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV Biomarkers
Cancers·2025Open Access
A phase Il trial to assess the impact of β2 adrenergic receptor (β2-AR) blockade in metastatic triple negative breast cancer (mTNBC).
Journal of Clinical Oncology·2025
Plant-based diet, inflammation biomarkers and body composition among women with breast cancer: the Pathways Study
British Journal Of Nutrition·2025· 3 citedOpen Access
Figure S4 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Figure S2 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Figure S1 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Figure S7 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Data from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Figure S5 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Figure S6 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Figure S3 from NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
2024Open Access
Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors
Cancers·2024Open Access
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs
Cancer Immunology Research·2024· 5 citedOpen Access
A phase II trial to assess the impact of β2 adrenergic blockade in immune checkpoint inhibitor (ICI)– refractory metastatic triple negative breast cancer (mTNBC).
Journal of Clinical Oncology·2024
Abstract CT210: Phase Ib/II study of sorafenib (SOR) and pembrolizumab (PEM) in patients (pts) with advanced hepatocellular carcinoma (HCC)
Cancer Research·2024
Abstract 3966: NK receptors enable TCR-mediated CTL recognition and killing of cancer cells expressing non-mutated tumor-associated antigens
Cancer Research·2024
page 1 of 10Next →

Frequent Co-authors

Kieran L. O’Loughlin(19), Maria R. Baer(12), Orla Maguire(10), Paul K. Wallace(7), Youcef M. Rustum(6), Kunle Odunsi(5), Cheryl Allen(4), Marc S. Ernstoff(4), Richard B. Bankert(4), U. Vanhoefer(4), William R. Greco(3), Shin La Shu(3), Tracy A. Brooks(3), Attaya Suvannasankha(3), Jenni Loyall(3), Raymond J. Kelleher(3), Károly Tóth(3), Carol Wrzosek(3), Marilyn L. Slovak(3), Shousong Cao(3)